过去十年，全球诸多研究机构——哈佛医学院、斯坦福大学、剑桥大学等——已纷纷确认：造血干细胞功能的退化，是机体系统性衰老最早、最关键的信号之一。相比皮肤、器官或激素，HSCs的变化更早、更本质，也更具干预意义。

Allo-HSCT是有望治愈恶性血液病、造血衰竭性疾病、先天免疫缺陷病等重大临床疾病的关键手段。然而，临床治疗中即便采用了有效的免疫抑制剂进行预防，移植后aGVHD依旧是allo-HSCT后常见的并发症，也是导致移植相关死亡的主要原因。现今防治多聚焦 ...

3月31日，中国科学技术大学附属第一医院血液内科占成教授、朱小玉主任医师，于国际学术期刊《细胞》（Cell）发表重要论文——Optimizing Stem Cell Infusion Timing in the Prevention of Acute ...

A senior undergraduate from Shanghai-based East China University of Science and Technology completed a donation of ...

Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...

LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with ...

Mar. 11, 2025 — Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences ...

Expectant families in the UAE now have access to an affordable, personalised medical resource that increases the likelihood ...

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies ...